{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:55:56Z","timestamp":1792266956113,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7404","license":[{"start":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T00:00:00Z","timestamp":1337731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T00:00:00Z","timestamp":1337731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2012,6,28]]},"DOI":"10.1038\/nature11147","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T13:21:22Z","timestamp":1337692882000},"page":"554-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":657,"title":["Immune self-reactivity triggered by drug-modified HLA-peptide repertoire"],"prefix":"10.1038","volume":"486","author":[{"given":"Patricia T.","family":"Illing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian P.","family":"Vivian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine L.","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Kostenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandvi","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kjer-Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Rossjohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,23]]},"reference":[{"key":"BFnature11147_CR1","first-page":"3","volume":"1","author":"J McCluskey","year":"1999","unstructured":"McCluskey, J. & Peh, C. A. The human leucocyte antigens and clinical medicine: an overview. Rev. Immunogenet. 1, 3\u201320 (1999)","journal-title":"Rev. Immunogenet."},{"key":"BFnature11147_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1126\/science.272.5258.67","volume":"272","author":"P Parham","year":"1996","unstructured":"Parham, P. & Ohta, T. Population biology of antigen presentation by MHC class I molecules. Science 272, 67\u201374 (1996)","journal-title":"Science"},{"key":"BFnature11147_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-010611-134701","volume":"52","author":"M Bharadwaj","year":"2012","unstructured":"Bharadwaj, M. et al. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Annu. Rev. Pharmacol. Toxicol. 52, 401\u2013431 (2012)","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BFnature11147_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung, W. H. et al. Medical genetics: a marker for Stevens\u2013Johnson syndrome. Nature 428, 486 (2004)","journal-title":"Nature"},{"key":"BFnature11147_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ng.379","volume":"41","author":"AK Daly","year":"2009","unstructured":"Daly, A. K. et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nature Genet. 41, 816\u2013819 (2009)","journal-title":"Nature Genet."},{"key":"BFnature11147_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","volume":"359","author":"S Mallal","year":"2002","unstructured":"Mallal, S. et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359, 727\u2013732 (2002)","journal-title":"Lancet"},{"key":"BFnature11147_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","volume":"359","author":"S Hetherington","year":"2002","unstructured":"Hetherington, S. et al. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 359, 1121\u20131122 (2002)","journal-title":"Lancet"},{"key":"BFnature11147_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","volume":"28","author":"D Chessman","year":"2008","unstructured":"Chessman, D. et al. Human leukocyte antigen class I-restricted activation of CD8+ T\u2009cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 28, 822\u2013832 (2008)","journal-title":"Immunity"},{"key":"BFnature11147_CR9","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.4049\/jimmunol.166.2.1016","volume":"166","author":"AW Purcell","year":"2001","unstructured":"Purcell, A. W. et al. Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J. Immunol. 166, 1016\u20131027 (2001)","journal-title":"J. Immunol."},{"key":"BFnature11147_CR10","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4049\/jimmunol.158.4.1660","volume":"158","author":"LD Barber","year":"1997","unstructured":"Barber, L. D. et al. Polymorphism in the \u03b11 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. J. Immunol. 158, 1660\u20131669 (1997)","journal-title":"J. Immunol."},{"key":"BFnature11147_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.immuni.2009.09.025","volume":"31","author":"WA Macdonald","year":"2009","unstructured":"Macdonald, W. A. et al. T cell allorecognition via molecular mimicry. Immunity 31, 897\u2013908 (2009)","journal-title":"Immunity"},{"key":"BFnature11147_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.it.2008.02.005","volume":"29","author":"JK Archbold","year":"2008","unstructured":"Archbold, J. K., Macdonald, W. A., Burrows, S. R., Rossjohn, J. & McCluskey, J. T-cell allorecognition: a case of mistaken identity or d\u00e9j\u00e0 vu? Trends Immunol. 29, 220\u2013226 (2008)","journal-title":"Trends Immunol."},{"key":"BFnature11147_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nri1977","volume":"6","author":"SJ Turner","year":"2006","unstructured":"Turner, S. J., Doherty, P. C., McCluskey, J. & Rossjohn, J. Structural determinants of T-cell receptor bias in immunity. Nature Rev. Immunol. 6, 883\u2013894 (2006)","journal-title":"Nature Rev. Immunol."},{"key":"BFnature11147_CR14","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","volume":"128","author":"TM Ko","year":"2011","unstructured":"Ko, T. M. et al. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens\u2013Johnson syndrome. J. Allergy Clin. Immunol. 128, 1266\u20131276 (2011)","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnature11147_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.it.2005.11.001","volume":"27","author":"SR Burrows","year":"2006","unstructured":"Burrows, S. R., Rossjohn, J. & McCluskey, J. Have we cut ourselves too short in mapping CTL epitopes? Trends Immunol. 27, 11\u201316 (2006)","journal-title":"Trends Immunol."},{"key":"BFnature11147_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1517\/phgs.5.2.203.27481","volume":"5","author":"AR Hughes","year":"2004","unstructured":"Hughes, A. R. et al. Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations. Pharmacogenomics 5, 203\u2013211 (2004)","journal-title":"Pharmacogenomics"},{"key":"BFnature11147_CR17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMoa0706135","volume":"358","author":"S Mallal","year":"2008","unstructured":"Mallal, S. et al. HLA-B*5701 screening for hypersensitivity to abacavir. N. Engl. J. Med. 358, 568\u2013579 (2008)","journal-title":"N. Engl. J. Med."},{"key":"BFnature11147_CR18","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1073\/pnas.0307067101","volume":"101","author":"AM Martin","year":"2004","unstructured":"Martin, A. M. et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc. Natl Acad. Sci. USA 101, 4180\u20134185 (2004)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature11147_CR19","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung, S. I. et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc. Natl Acad. Sci. USA 102, 4134\u20134139 (2005)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature11147_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/eji.1830090709","volume":"9","author":"FM Brodsky","year":"1979","unstructured":"Brodsky, F. M., Bodmer, W. F. & Parham, P. Characterization of a monoclonal anti-\u03b22-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur. J. Immunol. 9, 536\u2013545 (1979)","journal-title":"Eur. J. Immunol."},{"key":"BFnature11147_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0014-5793(02)03149-6","volume":"527","author":"W Macdonald","year":"2002","unstructured":"Macdonald, W. et al. Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex. FEBS Lett. 527, 27\u201332 (2002)","journal-title":"FEBS Lett."},{"key":"BFnature11147_CR22","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.4049\/jimmunol.148.6.1941","volume":"148","author":"J Zemmour","year":"1992","unstructured":"Zemmour, J., Little, A. M., Schendel, D. J. & Parham, P. The HLA-A,B \u2018negative\u2019 mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148, 1941\u20131948 (1992)","journal-title":"J. Immunol."},{"key":"BFnature11147_CR23","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.4049\/jimmunol.138.6.1657","volume":"138","author":"WJ Storkus","year":"1987","unstructured":"Storkus, W. J., Howell, D. N., Salter, R. D., Dawson, J. R. & Cresswell, P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 138, 1657\u20131659 (1987)","journal-title":"J. Immunol."},{"key":"BFnature11147_CR24","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1107\/S0907444904011679","volume":"60","author":"AW Schuttelkopf","year":"2004","unstructured":"Schuttelkopf, A. W. & van Aalten, D. M. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 60, 1355\u20131363 (2004)","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnature11147_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010)","journal-title":"J. Comput. Chem."},{"key":"BFnature11147_CR26","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1107\/S0907444906027636","volume":"62","author":"G Roder","year":"2006","unstructured":"Roder, G. et al. Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype. Acta Crystallogr. D Biol. Crystallogr. 62, 1300\u20131310 (2006)","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnature11147_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nbt957","volume":"22","author":"AL Szymczak","year":"2004","unstructured":"Szymczak, A. L. et al. Correction of multi-gene deficiency in vivo using a single \u2018self-cleaving\u2019 2A peptide-based retroviral vector. Nature Biotechnol. 22, 589\u2013594 (2004)","journal-title":"Nature Biotechnol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature11147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature11147","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature11147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T07:17:09Z","timestamp":1744355829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature11147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,23]]},"references-count":27,"journal-issue":{"issue":"7404","published-print":{"date-parts":[[2012,6,28]]}},"alternative-id":["BFnature11147"],"URL":"https:\/\/doi.org\/10.1038\/nature11147","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.716748153.793153143","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.716748153.792103208","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.716748153.793465298","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.716748153.793052817","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.716748153.793153308","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.716748153.793464378","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.716748153.793453562","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,23]]},"assertion":[{"value":"6 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}